GlobeImmune Files IPO to Raise $69M for Tarmogens
By Catherine Shaffer
Thursday, July 5, 2012
GlobeImmune Inc. filed for a $69 million initial public offering (IPO) to advance its cancer and infectious disease products developed using the Tarmogen platform.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.